Literature DB >> 6876745

Multinucleation enhances macrophage-mediated bone resorption.

M D Fallon, S L Teitelbaum, A J Kahn.   

Abstract

The degradation of mineralized connective tissues in vivo is a function of multinucleated giant cells ('clasts) derived from and belonging to the mononuclear phagocyte family. However, it is not known whether the attainment of the multinucleated state is causally or only coincidentally related to 'clast degradative activity. To address this issue, 'clast-like polykaryons were produced by exposing elicited rat macrophages to human serum (10% for 7 to 14 days). Pure populations (90%) of multinucleated cells and their mononuclear macrophage counterparts were then assessed for their ability to bind and degrade 45Ca-labeled, devitalized bone particles in vitro. Macrophage polykaryons bind bone particles significantly more effectively than ordinary elicited mononuclear macrophages (approximately 40% attachment versus approximately 25%; p less than 0.001). Similarly, 'clast-like polykaryons resorb both large (24 to 43 microns diameter) and small (less than or equal to 24 microns) particles more efficiently than age- and culture condition-matched mononuclear cells (treated to control ratios, 1.3 to 4.2:1, p less than 0.001). This difference in degradative activity remains highly significant whether resorption (45Ca release) is expressed per microgram of DNA, per 100 micrograms of protein, or per total cell surface area. We conclude that multinucleation produces qualitative changes in the resorptive capacity of macrophagic cells. The data suggest that the formation of polykaryons is a physiologically important event in 'clast development.

Entities:  

Mesh:

Year:  1983        PMID: 6876745

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

1.  Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.

Authors:  Susan A Steitz; Mei Y Speer; Marc D McKee; Lucy Liaw; Manuela Almeida; Hsueh Yang; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Use of monoclonal antibodies to recognise osteoclasts in routinely processed bone biopsy specimens.

Authors:  N A Athanasou; B Puddle; J Quinn; C G Woods
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

Review 3.  The pathobiology of the osteoclast.

Authors:  T J Chambers
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

4.  Comparison of the mechanisms of bone resorption induced by 1 alpha,25-dihydroxyvitamin D3 and lipopolysaccharides.

Authors:  Y Shiina; A Yamaguchi; H Yamana; E Abe; S Yoshiki; T Suda
Journal:  Calcif Tissue Int       Date:  1986-07       Impact factor: 4.333

5.  Osteoclast generation from human fetal bone marrow in cocultures with murine fetal long bones. A model for in vitro study of human osteoclast formation and function.

Authors:  M H Helfrich; C W Thesingh; R H Mieremet; A S van Iperen-van Gent
Journal:  Cell Tissue Res       Date:  1987-07       Impact factor: 5.249

6.  When is it an osteoclast?

Authors:  M Kaye
Journal:  J Clin Pathol       Date:  1984-04       Impact factor: 3.411

Review 7.  Vitamin D, phagocyte differentiation and immune function.

Authors:  T K Gray; M S Cohen
Journal:  Surv Immunol Res       Date:  1985

8.  Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

9.  A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.

Authors:  V W Engleman; G A Nickols; F P Ross; M A Horton; D W Griggs; S L Settle; P G Ruminski; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

10.  Bone resorption by cells isolated from rheumatoid synovium.

Authors:  J S Chang; J M Quinn; A Demaziere; C J Bulstrode; M J Francis; R B Duthie; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.